Schedule 13G ownership disclosure

SYNAGEVA BIOPHARMA CORP

Security class unavailable · CUSIP: 87159A103

Event date: 2014-12-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
2,190,074
Percent of class
6.5000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000858744-15-000020
Form type
SC 13G/A
Filer
SMALLCAP WORLD FUND INC
CIK
CIK 858744
Filed
Feb 13, 2015
Reporting period
Dec 31, 2014
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub